INVA earnings date and last-quarter result: last quarter beat, P/E 3.05. Updated 2026-07-23.
Innoviva (INVA) Research Hub
Innoviva (INVA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 21.05 USD (+1.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 3.05, market cap 1.58B. This hub links to the full technical, earnings and options research available for INVA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 21.05 USD (+1.89%) |
| 52-week range | 20.2 USD – 24.17 USD |
| Trend regime | Range |
| 14-day RSI | 52.8 (Neutral) |
| Trailing P/E | 3.05 |
| Market cap | 1.58B |
| Dividend yield | 0.00% |
Available research for INVA
Covered Call on INVA: how it works, illustrative setup around the real 21.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INVA: how it works, illustrative setup around the real 21.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INVA: how it works, illustrative setup around the real 21.05 USD price, max profit/loss, breakeven and when to use it. Educational.
INVA technical analysis: range, last 21.05 USD, RSI 52.8, 52w range 20.2 USD–24.17 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is INVA in?
Innoviva (INVA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INVA in an uptrend or downtrend?
As of 2026-10-26, INVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INVA's trailing P/E ratio?
INVA's trailing P/E is 3.05, with a market cap of 1.58B. See the earnings research page for full valuation detail.